vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $208.9M, roughly 1.1× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -35.0%, a 37.7% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
CCRN vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $236.8M | $208.9M |
| Net Profit | $-82.9M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | -30.2% | 1.1% |
| Net Margin | -35.0% | 2.7% |
| Revenue YoY | -23.6% | 27.1% |
| Net Profit YoY | -2109.7% | 518.5% |
| EPS (diluted) | $-2.56 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $208.9M | ||
| Q3 25 | $250.1M | $192.9M | ||
| Q2 25 | $274.1M | $186.7M | ||
| Q1 25 | $293.4M | $158.7M | ||
| Q4 24 | $309.9M | $164.3M | ||
| Q3 24 | $315.1M | $147.5M | ||
| Q2 24 | $339.8M | $148.0M | ||
| Q1 24 | $379.2M | $131.9M |
| Q4 25 | $-82.9M | $5.6M | ||
| Q3 25 | $-4.8M | $-5.2M | ||
| Q2 25 | $-6.7M | $-14.2M | ||
| Q1 25 | $-490.0K | $-30.7M | ||
| Q4 24 | $-3.8M | $-1.3M | ||
| Q3 24 | $2.6M | $-46.2M | ||
| Q2 24 | $-16.1M | $-20.1M | ||
| Q1 24 | $2.7M | $-45.7M |
| Q4 25 | — | 70.9% | ||
| Q3 25 | 20.4% | 71.1% | ||
| Q2 25 | 20.4% | 71.2% | ||
| Q1 25 | 20.0% | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | 20.4% | 68.8% | ||
| Q2 24 | 20.8% | 69.9% | ||
| Q1 24 | 20.4% | 66.3% |
| Q4 25 | -30.2% | 1.1% | ||
| Q3 25 | -2.4% | -4.4% | ||
| Q2 25 | -2.1% | -10.0% | ||
| Q1 25 | -0.3% | -20.5% | ||
| Q4 24 | -1.1% | -2.5% | ||
| Q3 24 | 0.9% | -34.1% | ||
| Q2 24 | -5.7% | -15.5% | ||
| Q1 24 | 0.8% | -28.9% |
| Q4 25 | -35.0% | 2.7% | ||
| Q3 25 | -1.9% | -2.7% | ||
| Q2 25 | -2.4% | -7.6% | ||
| Q1 25 | -0.2% | -19.3% | ||
| Q4 24 | -1.2% | -0.8% | ||
| Q3 24 | 0.8% | -31.3% | ||
| Q2 24 | -4.7% | -13.6% | ||
| Q1 24 | 0.7% | -34.6% |
| Q4 25 | $-2.56 | $0.18 | ||
| Q3 25 | $-0.15 | $-0.16 | ||
| Q2 25 | $-0.20 | $-0.44 | ||
| Q1 25 | $-0.02 | $-0.97 | ||
| Q4 24 | $-0.13 | $-0.03 | ||
| Q3 24 | $0.08 | $-1.48 | ||
| Q2 24 | $-0.47 | $-0.65 | ||
| Q1 24 | $0.08 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $152.7M |
| Total Assets | $449.0M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $583.8M | ||
| Q3 25 | $99.1M | $565.2M | ||
| Q2 25 | $81.2M | $545.5M | ||
| Q1 25 | $80.7M | $520.6M | ||
| Q4 24 | $81.6M | $535.6M | ||
| Q3 24 | $64.0M | $522.0M | ||
| Q2 24 | $69.6M | $561.5M | ||
| Q1 24 | $5.2M | $569.1M |
| Q4 25 | $322.8M | $152.7M | ||
| Q3 25 | $408.1M | $121.9M | ||
| Q2 25 | $412.2M | $103.7M | ||
| Q1 25 | $418.2M | $86.7M | ||
| Q4 24 | $419.0M | $90.9M | ||
| Q3 24 | $424.7M | $71.8M | ||
| Q2 24 | $433.3M | $99.2M | ||
| Q1 24 | $462.4M | $90.3M |
| Q4 25 | $449.0M | $1.0B | ||
| Q3 25 | $538.2M | $995.2M | ||
| Q2 25 | $553.8M | $964.0M | ||
| Q1 25 | $576.2M | $926.1M | ||
| Q4 24 | $589.3M | $931.4M | ||
| Q3 24 | $597.4M | $909.7M | ||
| Q2 24 | $602.9M | $919.2M | ||
| Q1 24 | $648.4M | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $26.2M |
| Free Cash FlowOCF − Capex | $16.1M | $14.5M |
| FCF MarginFCF / Revenue | 6.8% | 6.9% |
| Capex IntensityCapex / Revenue | 0.9% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $26.2M | ||
| Q3 25 | $20.1M | $34.9M | ||
| Q2 25 | $4.2M | $27.7M | ||
| Q1 25 | $5.7M | $-7.9M | ||
| Q4 24 | $24.2M | $19.2M | ||
| Q3 24 | $7.5M | $24.3M | ||
| Q2 24 | $82.4M | $11.8M | ||
| Q1 24 | $6.0M | $-52.0M |
| Q4 25 | $16.1M | $14.5M | ||
| Q3 25 | $17.9M | $20.1M | ||
| Q2 25 | $2.3M | $17.3M | ||
| Q1 25 | $3.8M | $-17.3M | ||
| Q4 24 | $21.7M | $12.4M | ||
| Q3 24 | $6.3M | $15.5M | ||
| Q2 24 | $79.6M | $3.4M | ||
| Q1 24 | $3.8M | $-61.8M |
| Q4 25 | 6.8% | 6.9% | ||
| Q3 25 | 7.2% | 10.4% | ||
| Q2 25 | 0.8% | 9.3% | ||
| Q1 25 | 1.3% | -10.9% | ||
| Q4 24 | 7.0% | 7.5% | ||
| Q3 24 | 2.0% | 10.5% | ||
| Q2 24 | 23.4% | 2.3% | ||
| Q1 24 | 1.0% | -46.8% |
| Q4 25 | 0.9% | 5.6% | ||
| Q3 25 | 0.9% | 7.7% | ||
| Q2 25 | 0.7% | 5.6% | ||
| Q1 25 | 0.6% | 5.9% | ||
| Q4 24 | 0.8% | 4.2% | ||
| Q3 24 | 0.4% | 6.0% | ||
| Q2 24 | 0.8% | 5.7% | ||
| Q1 24 | 0.6% | 7.4% |
| Q4 25 | — | 4.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |